Provided by Tiger Fintech (Singapore) Pte. Ltd.

Sunesis Pharmaceuticals

5.32
+0.0000
Volume:- -
Turnover:- -
Market Cap:27.52M
PE:-0.85
High:5.32
Open:5.32
Low:5.32
Close:5.32
Loading ...
May 28, 2021

Major Issues Report

8-K - Current report
May 13, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 12, 2021

Major Issues Report

8-K - Current report
Apr 14, 2021

Major Issues Report

8-K - Current report
Apr 02, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Apr 01, 2021

Major Issues Report

8-K - Current report
Mar 23, 2021

Major Issues Report

8-K - Current report
Mar 23, 2021

Major Issues Report

8-K/A [Amend] - Current report
Mar 11, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Mar 08, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Mar 05, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Mar 04, 2021

Major Issues Report

8-K - Current report
Mar 02, 2021

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Feb 24, 2021

Major Issues Report

8-K - Current report
Feb 24, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 23, 2021

Major Issues Report

8-K - Current report
Feb 16, 2021

Business Combinations

425 - Prospectuses and communications, business combinations
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals